Powder: -20°C for 3 years | In solvent: -80°C for 1 year
JZP-430 is an effective, highly selective, irreversible inhibitor of α/β-hydrolase domain 6 (ABHD6) (IC50: 44 nM). It also shows ~230-fold selectivity over fatty acid amide hydrolase (FAAH) and lysosomal acid lipase (LAL).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 101.00 | |
5 mg | In stock | $ 203.00 | |
10 mg | In stock | $ 307.00 | |
25 mg | In stock | $ 563.00 | |
50 mg | In stock | $ 793.00 | |
100 mg | In stock | $ 1,080.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 217.00 |
Description | JZP-430 is an effective, highly selective, irreversible inhibitor of α/β-hydrolase domain 6 (ABHD6) (IC50: 44 nM). It also shows ~230-fold selectivity over fatty acid amide hydrolase (FAAH) and lysosomal acid lipase (LAL). |
Targets&IC50 | ABHD6:44 nM(Human) |
Molecular Weight | 354.47 |
Formula | C16H26N4O3S |
CAS No. | 1672691-74-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 90 mg/mL (253.9 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
JZP-430 1672691-74-5 Metabolism MAGL Lipase Monoacylglycerol lipase inhibit JZP430 Inhibitor JZP 430 inhibitor